Management of nutrition support in adults with moderate-severe traumatic brain injury in the acute care setting by LeDuc, Grayson
Creative Components Iowa State University Capstones, Theses and Dissertations 
Spring 2020 
Management of nutrition support in adults with moderate-severe 
traumatic brain injury in the acute care setting 
Grayson LeDuc 
Follow this and additional works at: https://lib.dr.iastate.edu/creativecomponents 
 Part of the Dietetics and Clinical Nutrition Commons 
Recommended Citation 
LeDuc, Grayson, "Management of nutrition support in adults with moderate-severe traumatic brain injury 
in the acute care setting" (2020). Creative Components. 524. 
https://lib.dr.iastate.edu/creativecomponents/524 
This Creative Component is brought to you for free and open access by the Iowa State University Capstones, 
Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Creative 
Components by an authorized administrator of Iowa State University Digital Repository. For more information, 
please contact digirep@iastate.edu. 
Management of Nutrition Support in Adults with Moderate-Severe Traumatic Brain Injury in the 
Acute Care Setting 
 
Grayson LeDuc, RDN, LD 
 
Seeking Masters of Family and Consumer Sciences  
Emphasis in Dietetics 
 
April 14, 2020 
  
TABLE OF CONTENTS 
STATEMENT OF PURPOSE - 3 - 
METHODOLOGY - 4 - 
ABBREVIATIONS - 5 - 
REVIEW OF LITERATURE - 6 - 
Introduction - 6 - 
Nutritional Needs and TBI - 9 - 
Energy Needs - 9 - 
Protein Needs - 13 - 
Dysphagia - 13 - 
Nutrition Support and TBI - 14 - 
Enteral Nutrition - 15 - 
Parenteral Nutrition - 18 - 
Transition to Oral Diet - 19 - 
Long-Term Nutrition Support - 20 - 
Immunonutrition and TBI - 21 - 
Omega-3 Fatty Acids - 21 - 
Zinc - 23 - 
Glutamine - 24 - 
Conclusion - 24 - 
BIBLIOGRAPHY - 26 - 
APPENDIX A - 39 - 
Case Study - 39 - 
 
  
 - 3 - 
STATEMENT OF PURPOSE 
The purpose of this creative component project is to conduct a literature review 
examining the nutritional needs in adults admitted to the acute-care setting with moderate to 
severe traumatic brain injuries. Traumatic brain injury (TBI) is a public health concern as it 
impacts thousands of individuals each year and frequently results in disability or death. Nutrition 
plays an integral role in helping to manage the secondary injuries that may happen in the acute 
phase in individuals who suffer from a head trauma.  
My current position is that of a clinical dietitian serving multiple medical neurology and 
neurosurgical wards as well as a neurosciences intensive care unit. In this position, I work with 
many patients who have experienced a TBI of varying degrees. As I have come across patients 
with severe TBIs, I have learned how these patients are reliant on nutrition support and realized 
that nutrition recommendations in regard to this population are an area that I wanted to learn 
more. The goal of this creative component is to help increase my knowledge on the Medical 
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METHODOLOGY 
The articles used for this review of literature were gathered online from Pubmed, Ovid 
Medline and Embase. Pertinent search terms were used to locate peer-reviewed articles through 
these platforms include brain injuries, traumatic brain injuries, nutrition therapy, nutrition 
support, immunonutrition and energy intake. After initial search for immunonutrition; omega-3 
fatty acids, glutamine, and zinc were selected as key nutrients and were included in the literature 
search. A search including all of these terms resulted in a total of 32 articles. Some limitations 
observed when conducting this review of literature included small sample sizes, lack of human 
studies, and lack of updated research (in the last 10 years). In the initial search, articles were 
narrowed to within the last 10 years however, this was expanded to include articles of any date 
due to the lack of current research. The articles were evaluated using the Academy of Nutrition 
and Dietetics’ (AND) Evidence Analysis Library (EAL) worksheet. 
 
Table 1. Inclusion and Exclusion Criteria for Review of Literature Articles  
Inclusion Criteria Exclusion Criteria 
Adults (age 18 years and older) Pediatrics (age 17 years and younger) 
Articles written in English Articles not available in English 
Full-Text Articles  Abstract Only 
Interventions in Acute Care Setting  Interventions for post-acute or rehab setting 
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ABBREVIATIONS 
 
ASPEN – American Society of Parenteral 
and Enteral Nutrition 
BMI – Body Mass Index 
CRRT – Continuous Renal Replacement 
Therapy 
CSF – Cerebrospinal Fluid 
CT – Computed Tomography  
DHA – Docosahexaenoic Acid 
ED – Emergency Department 
EPA – Eicosapentaenoic Acid
EVD – External Ventricular Drain 
GCS – Glasgow Coma Score  
IBW – Ideal Body Weight 
ICH – Intracerebral Hemorrhage 
IC – Indirect Calorimetry  
ICP – Intracranial Pressure 
ICU – Intensive Care Unit 
IDDSI – International Dysphagia Diet 
Standardization Initiative  
IL - Interleukin 
NG – Nasogastric 
NJ – Nasojejunal 
OT – Occupational Therapy 
PEG – Percutaneous Endoscopic 
Gastrostomy 
PEJ – Percutaneous Endoscopic 
Jejunostomy 
PUFA – Polyunsaturated Fatty Acid 
RD – Registered Dietitian 
SAH – Subarachnoid Hemorrhage 
SLP – Speech-Language Pathology TBI – Traumatic Brain Injury 
TSH – Thyroid Stimulating Hormone 
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REVIEW OF LITERATURE 
Introduction 
Traumatic Brain Injury (TBI) is a leading cause of death and disability in the United 
States.1 The Centers for Disease Control and Prevention (CDC) defines TBI as a disruption in the 
normal function of the brain that can be caused by a bump, blow, or jolt to the head or 
penetrating head injury.1 The primary injury can be a result of either a penetrating (open-head) or 
a non-penetrating (closed-head) injury.2 TBIs can occur from many common events including 
falls, vehicle-related collisions, violence, high-impact sports injuries, and explosive 
blasts/combat injuries. 2 Falls account for almost one-half (48%) of all TBI-related Emergency 
Department (ED) visits, which increases significantly in individuals aged 65 years and older 
(81%) 3 Although anyone can be at risk for a TBI, they are most commonly seen in children (less 
than 18 years of age) and older adults as well as males in any age group. 3 
Around 2.87 million TBI-related ED visits, hospitalizations and deaths are reported 
annually; with an average of 155 individuals who die daily from TBI-related injuries in the 
United States. 1,3 Additionally, approximately 5.3 million individuals live with a disability 
caused by a TBI.2 Acute management of this trauma is important for the prognosis and quality of 
life for the affected individual.1  
The term “mass lesion” is frequently used when referring to TBI injuries and describes 
the area of localized injury that may cause pressure within the brain. 2 Mass lesions in the context 
of TBI are most commonly hematomas and contusions. Hematomas are blood clots that may 
occur anywhere in the brain and include epidural hematomas (between the dura mater and the 
inside of the skull) and subdural hematomas (between the dura mater and arachnoid layer). 2 
Contusions that occur as a result of brain injury can result in bleeding within the brain tissues, or 
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intracerebral hemorrhage (ICH). 2 Subarachnoid hemorrhages (SAH), however are classified by 
bleeding into the subarachnoid space and are common after a TBI, even in mild cases. 2 The 
severity of TBI is assessed after initial resuscitation and within 48 hours of the injury and is 
typically classified by using the Glasgow Coma Scale (GCS) (Table 1).4 The GCS assess the 
verbal, motor skills and eye response and a severe TBI is generally graded by a GCS score less 
than 8, moderate is a score between 9-12, and 13-15 is considered a mild head injury. 
 
 
Due to our incomplete knowledge of the cellular and molecular mechanisms of TBI there 
are currently no therapies to reduce TBI-associated damage.5  This is why the majority of 
interventions are aimed at reducing secondary injuries in an effort to reduce total damage. 
Table 2. Glasgow Coma Scale with Scoring  3 
Eye Response 
Spontaneous  4 points 
To verbal stimuli, command, speech 3 points 
To pain only 2 points 
No response 1 point 
Verbal 
Response 
Oriented 5 points 
Confused Conversation, able to answer 
questions 
4 points 
Inappropriate Words 3 points 
Incomprehensible Speech 2 points 
No response  1 point 
Motor 
Response 
Obeys Commands  6 points 
Purposeful movement to painful stimuli 5 points 
Withdraws in response to pain 4 points 
Flexion in response to pain  3 points 
Extension in response to pain 2 points 
No response 1 point 
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Secondary injuries may include ischemia, hypoxia, hypotension, hypertension, cerebral edema, 
increased pressure in the skull, meningitis, biochemical changes and epilepsy.2 As a result of the 
secondary injury changes in levels of consciousness, memory disturbances, new onset or 
worsening of seizure disorder, visual field deficits, hemiparesis, dysphagia, and aphasia may 
occur. 2,3,6 
A more commonly used invasive intervention is the use of intracranial pressure (ICP) 
monitoring. The gold standard for ICP monitoring is the external ventricular drain (EVD), which 
is a catheter that is placed in the third ventricle of the brain.7 This is used to not only monitor 
pressure in the brain but also works to drain cerebrospinal fluid (CSF), which can help treat 
intracranial hypertension. Less invasive interventions that help manage secondary injuries 
include elevating the head of the bed to 30 degrees to promote venous drainage, mannitol therapy 
and hypertonic saline, which act as a diuretic to reduce ICP, and high dose barbiturate therapy to 
reduce ICP. 7,8 Surgical interventions may be needed if cerebral edema does not respond to non-
invasive treatments or is required by the degree of swelling.7 If surgery takes place it is usually a 
decompressive hemicraniectomy followed by eventual cranioplasty (bone flap replacement). 7  
The role of the registered dietitian (RD) is integral throughout the entirety of a patient’s 
recovery from a TBI. In the acute phase, the RD is responsible for determining the nutritional 
needs, guide the appropriate route for nutrition (e.g. parenteral vs. enteral nutrition) minimize 
complications of nutrition support, and eventually guide the transition from nutrition support to 
an oral diet. RDs can be invaluable to the patient in the outpatient setting to assist with weight 
management. In the rehabilitation phase after a TBI, patients often struggle with weight 
management as a result of behavior disturbances, cognitive impairment, side effects of 
medications, alcohol and tobacco use, poor motor function and poor sleep quality and fatigue.9,10  
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Nutritional Needs and TBI 
 After a brain injury, it is essential to provide adequate nutrition in order to maintain 
normal body processes and promote healing. The RD plays a primary role in determining 
estimated energy needs based on predictive equations. These equations may be influenced by the 
policies set by the particular health care system or facility, research-based best practices, and/or 
clinical judgement. The estimated energy needs are then used to determine if the patient’s intake 
is adequate to maintain their nutritional status through an oral diet or to guide nutrition support 
needs. Determining the energy and protein needs and the ability to consume an oral diet lays the 
foundation for effective nutrition interventions after a TBI.  
Energy Needs 
The body responds to trauma in a cascade of metabolic changes commonly called the ebb 
and flow response. The ebb phase, or decreased metabolic rate, occurs early following the injury 
which is characterized by a decrease in total body energy and nitrogen excretion in an effort to 
reduce energy depletion.11–13 This phase typically lasts less than 24 hours. Hemodynamic 
instability can occur due to decreased circulating volume. In this phase there is an increase in 
endocrine hormones such as catecholamines and cortisol, which leads to the flow phase. 13  
The ebb phase is followed by the flow phase, or the catabolic stage. After resuscitation 
from the shock of the trauma there is an increased metabolic turnover, activation of the immune 
system and induction of the hepatic acute-phase response. 11–13  This causes a significant increase 
in oxygen consumption and energy expenditure and is characterized by a negative protein 
balance (-3 to -16 g nitrogen per day). 14 In this phase the body’s primary function is to protect 
vital organ functions and rebuild tissue damage.13 When adequate energy and protein substrates 
are not available these functions suffer and places the patient in an increasingly critical state. In 
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the early catabolic stage an increase in catecholamines, glucagon, and corticoids, insulin 
resistance, cytokines, eicosanoids, and oxygen radicals produce a subsequent increase in energy 
production and consumption, which results in increased energy needs.12  Catabolism typically 
occurs in peripheral tissue such as muscle, adipose, and skin and is used to create the required 
response for wound healing.13 This response to stress can only be reversed through medical 
management such as reducing infection, inflammation and heat loss.12 Initiation of nutrition 
support can reduce negative energy and protein balance but may not completely reverse a 
negative protein balance until the anabolic stage begins. 12 
The final stage of the stress response is the anabolic stage. The transition from the 
catabolic to anabolic stage depends on the injury severity and may take several weeks after 
severe trauma. 13 This stage is characterized by the reduction of nitrogen excretion and is known 
as the corticoid withdrawal phase.15 The early stages of this phase may take weeks to months 
depending on nutrition supply and protein storage prior to injury and provision of nutritional 
needs post-injury.13 Nutrition support is impactful in the recovery of the patient during this 
phase, largely demonstrated by provision of ample protein and calorie intake. Achieving a 
positive nitrogen balance through adequate protein intake correlates to an increase in protein 
synthesis and progressive restoration of weight and muscle strength over a period of weeks to 
months. 
As is common with many trauma patients, those who have suffered a TBI also have a 
corresponding hypermetabolic state. While it has been historically well documented that there is 
an increase in energy needs, there is no clear consensus on the extent of hypermetabolism, reason 
for the increase, or the length in which energy needs are increased. 16,17 Studies have indicated 
that in the acute stage of head injury, energy needs vary from 87% to 200% of basal energy 
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needs.18 These energy needs may be increased for as long as 30 days in the post-injury stage. It 
also has been suggested that the GCS is inversely related to the degree of hypermetabolism 
indicating that lower GCS scores may require further increased energy needs. 9  
Indirect calorimetry (IC) is the gold standard for determining estimated energy needs in 
critically ill patients. 19,20 However, IC is rarely used in practice due to cost, equipment 
availability, and the many variables in the intensive care unit (ICU) that reduce the accuracy of 
the measurements (e.g., air leaks/chest tubes, supplemental oxygen, ventilator settings, 
continuous renal replacement therapy (CRRT), anesthesia, excessive movement, etc.).19 As a 
result, many practitioners rely on predictive energy equations to assess calorie needs, which 
results in a risk of over- or underfeeding the patient.  
The American Society for Parenteral and Enteral Nutrition (ASPEN) reported that when 
over 200 predictive equations were measured against IC none stood out against the others in the 
ICU. 19 Further, many of the formulas are frequently inaccurate in the ICU due to constantly 
changing variables such as medications, temperature and medical treatments. 1919 For instance, 
barbiturates, paralyzing agents, and sedatives can reduce energy needs by 12-36%. 18 Table 3 
outlines several energy equations. In critically ill patients who are non-obese, the Penn State 
equation is the most accurate (79%) followed by Swinamer (55%), and Ireton-Jones (52%).20 
However, Harris Benedict and simplified formulas (typically 25-30 kcal/kg in normal weight 
individuals with body mass index (BMI) <25 kg/m2) are frequently used in practice. 21  
Permissive underfeeding (reduced calorie intake, high protein intake) is a commonly used 
protocol in patients who are obese (>30 kg/m2) to preserve lean body mass, mobilize fat stores 
and minimize metabolic complications.22 Ultimately, it is critical for the practitioner to use 
clinical judgement and to take a multifactorial approach to determining energy needs.  
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In a case study comparing these common formulas conducted as part of this creative 
component, it was found that the Harris- Benedict, Mifflin-St. Jeor equations multiplied by a 
stress factor of 1.2-1.5, the simplified equation (25-30 kcal/kg) were comparable (Appendix A). 
In comparison, Penn-State, Swinamer, and Ireton-Jones equations multiplied by the same stress 
factor all had higher calorie estimates by an average of 266-364 kcal. In this case, indirect 
calorimetry is not available to determine actual requirements for comparison.  
Table 3. Equations for Estimated Energy Needs  
Penn State 20 RMR = (Mifflin – St. Jeor x 0.96) + (VE x 32) + (Tmax x 167) – 6212 
Tmax= max body temp in previous 24h (degrees Celsius); VE= minute 
ventilation (L/min) 
Swinamer 20 RMR = (BSA x 945) – (A x 6.4) + (Temp x 108) + (RR x 24.2) + (VT x 
81.7) – 4349 
BSA=body surface area (m2); A= age (years); Temp = degrees Celsius; 
RR= respiratory rate (breaths/min); VT = tidal volume (L) 
Ireton-Jones 20 RMR = 1784 – (11 x A) + (5 x W) + (244 x S) + (239 x T) + (804 x B) 
A= age (years); W=weight (kg); S=sex (1-male, 0-female); T= trauma 
(1-present, 0-absent); B=burns (1-present, 0-absent) 
Mifflin-St. Jeor 
20 
Men: RMR = 5 + (10 x W) + (6.25 x H) – (5 x A) 
Women: RMR = -161 + (10 x W) + (6.25 x H) – (5 x A) 
W=weight (kg); H=height (cm); A= age (years) 
Harris Benedict 
20 
Men: RMR = 66.47 + (13.75 x W) + (5 x H) – (6.76 x A) 
Women: RMR = 665.1 + (9.56 x W) + (1.7 x H) – (4.7 x A) 
W=weight (kg); H=height (cm); A= age (years) 
Simplified 21 BMI <25 kg/m2 - 25- 30 kcal/kg Actual BW  
BMI 30-50 kg/m2 – 11-14 kg/kg Actual BW 
BMI >50 kg/m2  - 22-25 kg/kg Ideal BW 
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Protein Needs 
 After trauma, protein is the most important macronutrient for healing wounds, 
maintaining lean body mass and supporting immune function. 21,23 ASPEN suggests using a 
simplistic equation of 1.2 to 2.0 g/kg of protein for individuals who are categorized as normal 
weight (BMI <25 kg/m2) in the ICU is sufficient. 21  For patient in the ICU who are categorized 
as obese, increased protein intake with permissive underfeeding is indicated. 22  ASPEN 
recommend providing up to 2 g/kg ideal body weight (IBW) for individual with a BMI of 30-40 
kg/m2 and up to 2.5 g/kg IBW for BMI ≥50 kg/m2.22  However, there are currently no studies 
available that have investigated the protein needs for patients with TBI. In order to provide 
adequate protein intake without providing excess calories, modular protein products (such as 
Beneprotein® or Prosource®) may be required. This is particularly important since overfeeding 
critically ill patients can cause hyperglycemia, increased carbon dioxide (CO2) production, 
increased risk of infection. 23  
Dysphagia 
Dysphagia, or impaired swallowing is a frequent TBI-related complication. Many factors 
that impair swallowing in these individuals including surgeries, prolonged disuse of swallowing 
muscles, medications that may impair swallowing function (e.g., muscle relaxers, medications 
that cause xerostomia, antipsychotics/ neuroleptics), intubation-related injuries, and prolonged 
intubation/tracheostomy placement. 24 For individuals with a severe TBI (GCS 3-5), computed 
tomography (CT) can show midline shift, brainstem involvement, and brain pathology which 
may require emergent operative intervention. These individuals are at the highest risk for 
abnormal swallow function, aspiration and delay in initiation of oral nutrition. 25  
 - 14 - 
The incidence of dysphagia is as high as 93% in individuals who have suffered a brain 
injury, although reports vary significantly.24,26–28 Identifying dysphagia is important as 
complications that arise from impaired swallowing can be contribute to secondary complications 
such as infections leading to longer hospital stays, increased cost, and can lead to weight loss, 
malnutrition and dehydration.29,30 Abdelmalik and others reported that 94% of individuals who 
were unable to safely consume oral nutrition at time of the initial injury were ultimately able to 
successful take oral nutrition with improvement in neurological status and therapy.7  
Dysphagia diets, such as the International Dysphagia Diet Standardization Initiative 
(IDDSI) provide a progression of textures from safest (e.g. pureed diet, pudding-thick/extremely 
thick liquids, etc.) to a regular diet.31 IDDSI is the framework facilities are adapting to help 
standardize dysphagia diet terminology and diet progression globally. 32 The goal of switching to 
standardized language and testing is to ensure quality and safety of the diet across all platforms 
and to ensure that the patient is receiving the highest standard of care. The RD, with help from 
the occupation therapy (OT) or speech language pathology (SLP) services, provide education 
and ensure compliance with the patient’s diet. Due to the inability to consume adequate oral 
intakes while swallow function is impaired, many individuals are reliant on nutrition support to 
meet their nutritional needs after a TBI.  
Nutrition Support and TBI 
 Nutrition support is needed when the patient is intubated, significantly impaired 
neurological status or is experiencing significant dysphagia. Early initiation of feeding is 
correlated with better outcomes including reduced infectious complications, positive effects on 
hormone profile (cortisol, thyroid stimulating hormone (TSH), free thyroxine, etc.), reduced risk 
of malnutrition, GCS recovery, and decreased the length of stay. 14,33–38 In addition,  patients fed 
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earlier rather than later show a tendency towards less morbidity and mortality and may reduce 
relative risk of disability. 34  Härtl and colleagues reported a two-fold increased likelihood of 
death in patients who were not fed within five days after injury and four-fold increase after seven 
days. 34 Furthermore, Härtl et al. found that the amount that they were fed in this first five days 
was also related to death with every 10-kcal/kg decrease in calorie intake being correlated to a 
30% to 40% increase in mortality. 39 RDs need to be part of the treatment team early to advocate 
for nutrition support in patients who are metabolically compromised to avoid complications 
associated with delayed nutrition. While there is substantial evidence to support the initiation of 
early nutrition support, there are conflicting reports of whether enteral or parenteral nutrition 
produces better outcomes in TBI patients.  Many studies have found that both routes are equally 
effective at meeting nutritional goals. 40–42  
Enteral Nutrition 
  ASPEN recommends enteral nutrition be provided if the gastrointestinal tract is 
functioning for most patients who have undergone trauma, including TBI. 19 Early enteral 
nutrition (within 24-48 hours) is beneficial as it supports the integrity of the gut by maintaining 
the intestinal barrier, stimulating blood flow, inducing release of trophic endogenous agents (e.g. 
cholecystokinin, gastrin, bombesin, and bile salts) and reduces infectious morbidity and ICU 
length of stay. 19,43  
A review of patients in the ICU with TBI suggests that as high as 94% of individuals 
required enteral nutrition. 44 There are many ways in which to administer enteral nutrition 
including nasogastric (NG), nasojejunal (NJ), percutaneous endoscopic gastrostomy (PEG), or 
percutaneous endoscopic jejunostomy (PEJ). The location and type of the tube depends on 
tolerance to enteral nutrition and the anticipated length of time the patient will require enteral 
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nutrition.19When it is determined that the patient cannot take nutrition orally an NG tube will be 
placed for nutrition. This is usually the first attempted route of nutrition as this can be completed 
at bedside by a nurse, physician, or dietitian and placement for this route can be easily confirmed 
by portable abdominal X-ray.45 An NG tube placement requires that the prolonged supine 
position be avoided, and the head of the bed should be maintained at 30-45 degrees during 
feeding to minimize the risk of aspiration. 46,47  
A post-pyloric (NJ) feeding tube may be indicated if the patient has to be in a prolonged 
supine position due to this high risk of aspiration during enteral nutrition or if vomiting and 
abdominal distention occur, 47 This is reserved for these patients as tubes placed post-pyloric 
must be done so under x-ray and may require justification for insurance to cover these tubes as 
an outpatient due to additional equipment needed. Post-pyloric feeding effectively meets 
nutrition requirements, reduce gastric residue, and improves gastrointestinal dysfunction that is 
typically seen with TBI patients. 48,49 
Many patients with TBI have altered gastrointestinal function after injury which can lead 
to feeding intolerance. Lee reported TBI was associated with twice the incidence of intolerance 
to gastric feeding compared to other trauma diagnoses. 43 It has also been suggested that 50% to 
80% of patients with head injuries exhibit delayed gastric liquid emptying compared to those 
who did not. 50,51 Altered gastric motility and emptying may occur as a result from the injury 
itself due to damage in the autonomic central nervous system or nerves. 51,52 Individuals who 
have undergone a trauma show decreased bowel sounds, gastroparesis, lack of cardiac response 
to tracheal stimulation and high gastric retention. 52  Many of these complications are related to 
vagal dysfunction related to peripheral autonomic dysfunction. It has been suggested that 
increased intracranial hypertension, especially in TBI patients, can lead to the suppression of 
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vagal activity and when this brain-gut link is altered this can result in gastric dysrhythmias and 
intolerance to enteral nutrition. 52,53 An increased ICP level and the severity of the TBI is related 
to the level of intolerance to tube feeds. 54 Intolerance to tube feeding frequently results in 
decreased delivery of enteral nutrition and increased length of ICU stay. 19 
Gastric motility issues typically last in the majority of patients with a head trauma for the 
first two weeks post injury. 14,51 Kao et al. reported patients with TBI were able to tolerate full 
enteral nutrition by day 16. 50 Common complications related to tolerance to tube feedings 
include interruptions for various medical interventions and unintentional removal of the feeding 
tube. 39 This can impede adequate nutrition in these patients, and with the extent of increased 
metabolic needs this places these patients at further risk for malnutrition. 39 Many individuals 
assess tolerance to enteral nutrition by measuring gastric residuals, which is the most common 
feeding intolerance. 53 Diarrhea is another common feeding intolerance for individuals receiving 
enteral nutrition. This is influenced by the type and amount of fiber in formula, osmolality of 
formula, delivery mode, EN contamination, medications (antibiotics, proton‐pump inhibitors, 
prokinetics, glucose lowering agents, nonsteroidal anti-inflammatory drugs (NSAIDs), laxatives, 
and sorbitol‐containing preparations), and infectious etiologies, including Clostridium difficile 
(C.Diff). 19 The RD can facilitate improved tolerance to enteral nutrition by recommending a 
slower advancement rate to goal feeds, changing the formula, transitioning to a continuous 
enteral nutrition schedule from intermittent, or advancement of the tip of the tube, if applicable. 
When other source of intolerance cannot be identified the introduction of prokinetic agents may 
be indicated.  
Providing prokinetic agents such as erythromycin or metoclopramide can help control 
these gastrointestinal disorders in TBI patients by speeding up gastric emptying and movement 
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in the upper GI tract, resulting in reduced gastric residuals.43,55,56 Dickerson and colleagues 
suggest that the combination of these medications is the more effective in improving gastric 
feeding than metoclopramide alone. 43 However, patients with TBI are typically less responsive 
to prokinetic therapy with an estimated three-fold probability of failure to metoclopramide 
therapy. 43 Additionally, in some instance barbiturates may be used to reduce ICP, which can 
severely hinder gastrointestinal motility and is commonly refractory to motility agents. 57 Failure 
to respond to metoclopramide may also be influenced by low serum albumin concentration, early 
initiation of enteral nutrition and prokinetic therapy, and high ICP. 43 If all interventions have 
been exhausted to improve tolerance of enteral nutrition, parenteral nutrition may be indicated.   
Parenteral Nutrition 
According to ASPEN guidelines, if the patient has a functioning gastrointestinal tract 
enteral nutrition is recommended, however some patients are unable to tolerate tube feeds and 
parenteral nutrition is indicated to meet nutrition needs. 19 After a TBI, parenteral nutrition 
provides significantly higher nitrogen intake which is recommended in critically ill patients to 
promote lean body mass and prevent catabolism .42 However, those receiving parenteral nutrition 
also resulted in increased nitrogen excretion; therefore, nitrogen balance was similar to those 
who were fed enterally. 41,42 Parenteral nutrition may also help decrease the risk of aspiration 
pneumonia. 58,59 However, results concerning the impact of parenteral nutrition on infection risk 
varies with many studies reporting no difference in serum albumin levels, weight loss, incidence 
of infection, or clinical outcome between parenterally and enterally fed patients. 40–42 Still, the 
studies that were available frequently compared early initiation of parenteral nutrition compared 
to late initiation of enteral nutrition, which may not be an accurate depiction of the positive 
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effects of parenteral nutrition. Furthermore, hyperglycemia that is common with parenteral 
nutrition and can lead to worse neurological outcomes.40,42,60 
Early parenteral nutrition may be indicated in individuals who receive high dose 
barbiturates due to reduced gastrointestinal motility which results in frequent intolerance to 
enteral nutrition. One study reported that all patients receiving barbiturate therapy failed 
nasogastric feeding within the first 48 hours of full induction into a barbiturate coma. 57 
Additionally, only 25% of these patients tolerated post-pyloric feedings within 48 hours. 
Therefore, early parenteral nutrition may be indicated in these patients. 
Transition to Oral Diet 
When a safe oral nutrition program is determined by the interdisciplinary team, which 
frequently involves a texture modified diet, patients can begin weaning from nutrition support. 
The average time for the patient to safely consume their first oral meal after injury is about three 
months.7 Buchholz originally describes a two-phase algorithm for weaning patients from tube 
feeding to oral nutrition: Preparatory Phase and Weaning Phase. 61 
The Preparatory Phase consists of stability from a medical and nutritional standpoint, a 
swallowing assessment by an OT or SLP, and the transition from continuous tube feeding to an 
intermittent feeding schedule.61 Intermittent tube feedings provide full nutrition needs over 
several 20-60 minute time periods every 4-6 hours through a gravity bag, pump or syringe.62  
This phase continues until a patient is cleared for an oral diet, which is determined by an OT or 
SLP.  
The Weaning Phase is the progression from therapeutic feeds to full oral nutrition and 
eventually discontinuing enteral nutrition. This involves providing supplemental tube feedings 
based on amount of meal eaten or nocturnal tube feeds. 61,63 For example, if a patient consumes 
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50% of a meal, only 50% of the goal tube feeding for that meal period would be given. 
(Appendix A) Once 75% of the patient’s nutritional needs are met through solid foods for a 
minimum of three days enteral nutrition can be discontinued.61 It is the RD’s role to provide oral 
nutrition supplements and counsel the patient on therapeutic diets to encourage adequate intake. 
During the weaning phase, the patient is monitored closely for aspiration, dehydration and to 
ensure that feeding and swallowing strategies as well as texture modifications to enable the 
patient to safely consume adequate oral intake. 61  
Long-Term Nutrition Support 
When long- term enteral access is expected based on functional/mental status and severity 
of dysphagia, a percutaneous endoscopic gastrostomy (PEG) or jejunostomy (PEJ) tube may be 
indicated. If the patient remains mechanically ventilated, an early intervention of combined 
tracheostomy and PEG placement, within the first seven days of injury, reduces ICU and hospital 
length of stay and shortens the course of mechanical ventilation compared to late intervention.64 
If the patient is able to be extubated but is unable to initiate a diet due to swallowing difficulties 
or neurological status a PEG tube may be indicated due to the length of time necessary to regain 
swallowing function. Additionally, most skilled nursing facilities and inpatient rehab centers will 
deny admission when the patient is medically stable for discharge if they have a nasogastric or 
jejunal feeding tube.65 Consideration for insurance approval should also be taken when 
considering PEG tube placement Medicare guidelines state that the patient must have a 
permanent (defined as greater than three months) impairment of structures that normally allow 
food to meet the stomach or small intestine, such as severe dysphagia. 66 Many other insurance 
providers mirror these guidelines although coverage may vary between insurance policies. 
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Insurance coverage generally continues if the patient is taking small bites of food by mouth for 
therapeutic purposes in an effort to transition to a full oral diet.  
Immunonutrition and TBI 
There is growing interest in using immunonutrition to modulate the inflammatory 
response to the TBI and to facilitate the reduction of a secondary injury. A TBI increases the 
levels of inflammatory cytokines, including interleukin-6 (IL-6), which is a key regulator of the 
inflammatory response. 67 Elevated IL-6 have been related to poor outcomes for patients with 
TBI. 67 
In response to the increased demand for immunonutrition, many enteral nutrition 
companies have created immune-modulating formulas that are available for patients with TBI in 
addition to use in patients who are admitted due to trauma or surgery.68 Many of these formulas 
are high protein to support the nutritional needs for healing and peptide-based to help with 
tolerance and digestion. Formulas marketed as immune-modulating are typically supplemented 
with arginine, glutamine, and omega-3 fatty acids. 69  Immune-modulating formulas containing 
omega-3 fatty acids, arginine, and glutamine decrease IL-6 levels in patients with TBI. 67,70 
However, immunonutrition may have no impact on mortality or length of stay. 71 
Omega-3 Fatty Acids 
 Long-chain polyunsaturated fatty acids (PUFA), particularly omega-6 and omega-3 fatty 
acids, are found in large quantities in the central nervous system (CNS).72,73 The human brain is 
made up of 60% lipid by dry weight and docosahexaenoic acid (DHA) comprises 50% of 
neuronal membrane phospholipids. 74 Although, omega-3 fatty acids show promise in helping 
with TBI, most studies have been conducted in mice and no clinical trial data is available in 
humans presently. 21 Fatty acids have an indirect role as metabolic precursors for eicosanoids 
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which play a role in platelet aggregation, neurotransmitter release, vascular function, infection 
responses, inflammatory activity, and immune system activity. 21,75 Alpha-linolenic acid, an 
essential fatty acid, is a precursor for DHA and eicosapentaenoic acid (EPA); however, because 
this conversion process is inefficient in obtaining DHA and EPA, intake through the diet is 
recommended. 21 EPA and DHA are both critical for eyesight and brain function. DHA is the 
most abundant in the CNS and is shown to have neuroprotective functions. 72,73 Omega-3 fatty 
acids are commonly found in flaxseed, fish and seafood, soybean and canola oils. 21 Some 
immune-enhancing enteral formulas, as well as the lipids that are compounded in parenteral 
nutrition may contain supplemented omega-3 fatty acids. 21  
Following a TBI, DHA and EPA are converted to neuroprotectins and resolvins which 
then prevent cell death and upregulate tissue repair. 21,76 Research using mice models suggests an 
intravenous DHA bolus in the first hour of trauma may significantly improve neurological 
outcome.73 This acute bolus rapidly changed the lipid mediator profile at the site of the injury 
and promotes a resolving mediator profile as early as three hours after administration. 73 
However, this effect may be lost if the administration is not given within four hours of injury. 73 
Omega-3 fatty acid supplementation for at least four weeks after injury may counteract long-
term learning disability related to the injury. 77–80 A case report reported by Lewis et. al. reports 
that providing a substantial amount (the patient received 9,756 mg EPA, 6756 mg DHA and 
19,212 mg total omega-3 fatty acids through PEG) provided early in treatment may have positive 
effects on recovery.81 Although research suggests that omega-3 fatty acid supplementation may 
be beneficial following a TBI, more studies in humans are lacking thus more research is needed.  
 - 23 - 
Zinc 
 Zinc is an essential trace metal strongly associated with neuronal and immune system 
health due to its role as an antioxidant. 4,82 Zinc works to inhibit anti-inflammatory responses that 
would typically cause oxidative stress, commonly seen in zinc deficiency. 4,82Zinc is also integral 
in the brain function across the lifespan by regulating gene expression as managing many key 
enzymes in neuronal metabolism. 82  Given the significant influence on brain function, it is 
suggested that alterations in zinc status can be responsible for many neurodegenerative disorders 
such as Alzheimer’s disease and mood disorder as well as neuronal damage associated with TBI, 
stroke and seizures.4 
Following a TBI the development of zinc deficiency is common. Along with zinc 
deficiency, there is evidence of continued cell death for four weeks following the injury.4,9 
Patients with TBI typically have elevated urinary zinc losses that persist for weeks following 
injury and result in reduced serum zinc levels.4 These urinary zinc losses are proportional to TBI 
severity.83 Providing patients who have had a TBI with 22-25 mg/day of zinc improves the rate 
of neurologic recovery and protein metabolism. 9,83 One study found that zinc supplementation 
(22 mg/d) compared to those receiving adequate zinc (2.5 mg/d) resulted in lower mortality rates 
(12% vs 26%, respectively) as well as significantly improved GCS scores in as early as two 
weeks after initiation. 9 Another found that prolonged zinc supplementation (25 mg/d) reduced 
physiological responses to stress and anxiety, improved cognitive behavior, and prevent 
impairment of spatial learning and memory. 83 Zinc supplementation is an inexpensive therapy 
and should be considered after a TBI due to the positive effects on neurologic recovery and lack 
of negative effects. 83 Long-term zinc supplementation should be used with caution due to its link 
with copper deficiency. 
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Glutamine 
Glutamine is a conditionally essential amino acid that plays a large role in cell 
maintenance through numerous functions. These functions include acting as a substrate for 
protein synthesis, as an anabolic precursor for muscle growth, acid-base balance in the kidney, 
substrate for ureagenesis in the liver, substrate for hepatic and renal gluconeogenesis, an 
oxidative fuel for intestine and cells of the immune system, inter-organ nitrogen transport, 
precursor for neurotransmitter synthesis, precursor for nucleotide and nucleic acid synthesis and 
as precursor for glutathione production. 21,84–86 A study in mechanically ventilated patients with 
TBI concluded that enteral nutrition supplemented with glutamine and probiotics reduces 
infection rate, decreases the occurrence of pneumonia, stress ulcers, and shortens the length of 
ICU stay. 87,88  
Although, there are many potential benefits to immunonutrition, it may be 
contraindicated for patients who are critically ill, including those with renal or liver disease. 
Rathmacher and colleagues found that blood urea was elevated in individuals who were 
receiving arginine and glutamine due to stimulation of ureagenesis. 89 As such, consideration 
should be given for patients who have comorbidities such as renal or liver disease prior to 
initiating immunonutrition. Despite the association between low glutamine concentration and 
poor outcome, early supplementation did not improve outcomes. 90 
Conclusion 
Early nutritional intervention to provide adequate nutrition is crucial for the survival and 
recovery of a patient following a TBI. The RD plays a major role in determining and guiding the 
Medical Nutrition Therapy. Specifically, the route of nutrition (oral vs. enteral vs. parenteral), as 
well as troubleshooting nutrition-related complications associated with TBI.  This review of 
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literature demonstrates that more research is needed to determine the best evidence-based 
nutritional support recommendations for treating TBI.   
Take Home Messages 
 As a result of this review of literature, many of these recommendations will be adapted to 
my current practice. Per my hospital’s policy I will calculate estimated energy needs using 
Harris-Benedict equation and select a stress factor of at least 120-150% of basal energy needs 
due to hypermetabolism seen after a TBI. I will use ASPEN guidelines to determine protein 
needs. Due to the metabolically compromised nature of this population, I will advocate for early 
initiation of enteral nutrition and will select a product that has immunological benefits such as 
Impact 1.5 peptide or Pivot 1.5. Additionally, I would like to incorporate checking zinc levels 
and providing supplementation when appropriate into my recommendations. Through this review 
I have become more aware of signs of intolerance as well as interventions to alleviate these and 
promote adequate nutrition and positive outcomes in this population.  
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APPENDIX A 
Case Study Comparing Various Energy Needs Equations 
Patient Description 
A 70-year-old male is admitted to the neurosciences ICU after being found unconscious after a 
fall. The patient was transferred to the unit intubated, mildly sedated on Precedex for agitation, 
which was quickly weaned and a nasogastric tube was placed. A CT scan of the head showed 
bilateral traumatic subdural, subarachnoid and intraparenchymal hemorrhages with a GCS of 7T 
(E1V1TM5). Patient is status-post decompressive hemi-craniotomy for management of cerebral 
edema. The patient’s respiratory rate is 16 breaths/min, tidal volume of 4.4 L, and minute 
ventilation is 7.04 L/min. Maximum temperature in the past 24 hours of 37.2 degrees Celsius. He 
is now 24 hours following injury and the RDN receives a consult for tube feeding management. 
Anthropometric Data: 
Height: 177.8 cm / 70”  Weight: 77.3 kg / 170 lbs  IBW:75.5 kg / 102% IBW  BMI: 24.5 kg/m2 
Body Surface Area: 1.95 m2 
RECOMMENDATIONS: 
Estimated Energy Needs:  
• Harris Benedict: RMR = 1543 kcal x SF (1.2-1.5) = 1852-2315 kcal 
• Simplified Equations: (25-30 kcal/kg) = 1933-2319 kcal 
• Mifflin-St. Jeor: RMR = 1542 kcal x SF (1.2-1.5) = 1850-2315 kcal 
• Ireton-Jones: RMR= 1884 kcal x SF (1.2-1.5) = 2260-2826 kcal  
• Penn State: RMR = 1706 kcal x SF (1.2-1.5) = 2047-2559 kcal  
• Swanimer: RMR= 1770 kcal x SF (1.2-1.5) = 2124-2655 kcal  
Protein Needs: 93-155 g protein (1.2-2.0 g/kg) 
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Enteral Nutrition Needs:  
RD recommends an initiation of an immune-modulating formula (such as Impact® 1.5 or Pivot® 
1.5) at 20 mL/hour with advancement of 10 mL every 8 hours until a goal rate of 55 mL/hour 
(1320 mL/day) to provide 1980 kcal (25.6 kcal/kg) , 124 g protein (1.6 g/kg), and meets 100% of 
recommended dietary intake of vitamins and minerals.  Both formulas provide 1500 kcal/L, 94 g 
protein/L and each provides glutamine, 3.7g/L (Pivot®) -4.9 g/L (Impact®) of DHA+ EPA, and 
13g/L (Pivot®) – 18.7 g/L (Impact®) of arginine. The RD also recommends checking a baseline 
zinc level and supplementing with 22-25 mg/day.  
It has been 48 hours after the initiation of enteral nutrition and the patient has 
reached his goal rate. He is exhibiting signs of gastric intolerance to tube feeds with 
abdominal distention and thick white secretions have been suctioned from endotracheal 
tube thought to be tube feeding.  
RECOMMENDATIONS: 
• Assessment of bowel function – may consider bowel regimen to stimulate regular bowel 
movements and improve gastric emptying. 
• A trial of metoclopramide or erythromycin to facilitate gastric emptying may be indicated.  
• Advancement of the tip of the tube into the jejunum may be indicated as a result of delayed 
gastric emptying and to reduce risk for aspiration.  
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It has been three months after injury and the patient has been stable on an 
intermittent regimen via PEG tube. His current regimen is 500 mL at breakfast, 500 mL at 
lunch and 250 mL at dinner of immune-enhancing formula. He has made significant 
neurological improvements and is now cleared to start a pureed diet with mildly thickened 
liquids.  
RECOMMENDATIONS: 
• Start a calorie count on the patient to assess daily energy and protein intake.  
• Provided intermittent tube feedings based on oral intakes at meals as follows: 
o If patient consumes ≤25% of meal, provide full feeding 
o If patient consumes 50% of meal, provide 50% of goal tube feeding 
o If patient consumes ≥75% of meal, hold tube feeding 
• Once patient is able to consume ≥75% of estimated energy needs based on calorie count 
results for at least 72 hours.  
 
